Filter
3519
Text search:
drug
safety
Featured
Recommendations
373
New Publications
948
Language
Document type
No document type
1943
Guidelines
591
Studies & Reports
494
Manuals
199
Strategic & Response Plan
131
Fact sheets
59
Training Material
49
Situation Updates
16
Resource Platforms
11
Infographics
11
Brochures
7
Online Courses
4
App
1
Videos
1
Countries / Regions
India
182
Kenya
105
Global
105
South Africa
87
Ethiopia
81
Uganda
77
Nigeria
72
Western and Central Europe
64
Sierra Leone
61
Tanzania
59
Liberia
56
Myanmar / Burma
52
Nepal
51
Zambia
51
Latin America and the Carribbean
47
Ghana
45
Bangladesh
45
Malawi
44
Namibia
43
Africa
42
Philippines
35
Rwanda
32
Zimbabwe
27
Eastern Europe
25
Russia
23
Cambodia
22
Asia
22
Ukraine
21
Syria
20
Lesotho
20
Botswana
18
South–East Asia Region
18
Germany
17
Indonesia
17
Brazil
15
Congo, Democratic Republic of
14
Middle East and North Africa
13
Eastern Europe and Central Asia
13
USA
11
South Sudan
11
Eswatini/ Swaziland
11
East and Southern Africa
11
West and Central Africa
11
Burkina Faso
9
Haiti
9
Mozambique
9
Vietnam
9
Cameroon
8
Pakistan
8
Thailand
8
Chile
8
Guinea
7
Senegal
7
Tajikistan
7
Afghanistan
6
Yemen
6
Venezuela
6
Albania
6
Laos
6
Colombia
5
Western Pacific Region
5
Iraq
4
China
4
Sudan
4
Argentina
4
Angola
4
Georgia
4
Guinea-Bissau
3
Somalia
3
Turkey
3
Peru
3
Switzerland
3
Libya
3
Sri Lanka
3
Paraguay
3
Bhutan
3
Moldova
3
United Kingdom
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Jordan
2
Lebanon
2
Central African Republic
2
North Macedonia
2
El Salvador
2
Palestine
2
Canada
2
Timor Leste/ East Timor
2
Iran
2
Uzbekistan
2
France
2
Saudi Arabia
1
Gambia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Benin
1
Austria
1
Serbia
1
Honduras
1
Bolivia
1
Madagascar
1
Mexico
1
Fiji
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Kyrgyzstan
1
Australia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
1322
Clinical Guidelines
343
Public Health
179
Women & Child Health
153
Key Resources
132
Capacity Building
54
Pharmacy & Technologies
52
Toolboxes
HIV
350
Mental Health
317
TB
254
AMR
220
COVID-19
211
Pharmacy
158
NTDs
121
Caregiver
86
Ebola & Marburg
72
NCDs
61
Malaria
58
Planetary Health
57
Rapid Response
55
Refugee
49
Conflict
45
Global Health Education
41
Disability
29
2.0 Rapid Response
23
Cholera
20
Specific Hazards
20
Natural Hazards
19
Zika
17
Health Financing Toolbox
15
Polio
14
Social Ethics
6
EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144.
Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and
...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi
...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities
...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by th
...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness,
...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classi
...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
This video highlights the significant risks that malaria poses to pregnant and breastfeeding women in malaria-endemic regions. It follows the stories of Angavu from Kenya, Moyinoluwa from Nigeria and Lamai from Thailand. It emphasises the severe consequences that malaria can have during pregnancy, i
...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme
...
Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr
...
Road safety is an issue that does not receive anywhere near the attention it deserves – and it really is one
of our great opportunities to save lives around the world
Therapeutics Information and Pharmacovigilance Centre | TIPC
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is att
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.